OpenVSafe by OpenVAERS
Search V-safe

6CU-26181-19442

3 vaccinations 1 coded response 5 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
554 / MN
Registered
2021-04-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-31
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-21
    Dose 2 — Pfizer-BioNTech
  3. 2021-04-22
    Registered in v-safe
  4. 2021-04-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Joint pains, Fatigue or tiredness · Be unable to work
    Adult check-in
  5. 2021-04-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site bruising — Feeling: Good
    Free text: Bruising at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-10-22
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  8. 2021-11-17
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  9. 2021-11-22
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Itching · None
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-31Pfizer-BioNTech
22021-04-21Pfizer-BioNTech
32021-11-17Pfizer-BioNTech Flu

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-25

Systemic reaction (other): Bruising at injection site

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROInjection site bruising ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release